The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

Subjects:

The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

Subjects:

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

Subjects:

The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

Subjects:

Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

Subjects:

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

Subjects:

¹³C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

Subjects:

General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

Subjects:

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

Subjects:

DIO Mice Liver Staining. by Xueqin lu (22250795)

Subjects:

Trends of peroxisome-related gene expression in liver tissue. by Xueqin lu (22250795)

Subjects:

NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

Subjects:

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

Subjects:

Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

Subjects:

The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

Subjects:

Synthesis process of Kylo-0603. by Xueqin lu (22250795)

Subjects:

ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

Subjects:

General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

Subjects:

Data Sheet 1_Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway.docx by Xinxin Li (281237)

“…In this study, we observed a significant upregulation of RPL9 in human B-ALL cells compared to normal B cells, suggesting RPL9’s potential key role in B-ALL progression. …”

Alterations in CBC parameters in albino rats of both genders after 60 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

Subjects: